Natalie Sacks
2020 - Harpoon Therapeutics
In 2020, Natalie Sacks earned a total compensation of $1.3M as Chief Medical Officer at Harpoon Therapeutics, a 144% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $184,800 |
|---|---|
| Option Awards | $678,119 |
| Salary | $440,000 |
| Other | $8,550 |
| Total | $1,311,469 |
Sacks received $678.1K in option awards, accounting for 52% of the total pay in 2020.
Sacks also received $184.8K in non-equity incentive plan, $440K in salary and $8.6K in other compensation.
Rankings
In 2020, Natalie Sacks' compensation ranked 7,432nd out of 13,090 executives tracked by ExecPay. In other words, Sacks earned more than 43.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,432 out of 13,090 | 43rd |
Division Manufacturing | 3,121 out of 5,618 | 44th |
Major group Chemicals And Allied Products | 1,259 out of 2,251 | 44th |
Industry group Drugs | 1,088 out of 1,951 | 44th |
Industry Biological Products, Except Diagnostic Substances | 258 out of 411 | 37th |
Source: SEC filing on March 24, 2021.
Sacks' colleagues
We found two more compensation records of executives who worked with Natalie Sacks at Harpoon Therapeutics in 2020.